Trial · NCT06386783
Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
NCT06386783, Phase 3, Unknown, Aswan University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects. Trials, record NCT06386783. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06386783
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
- NCT number
- NCT06386783
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 148 participants, estimated
- Lead sponsor
- Aswan University
- Conditions
- Dexmedetomidine, Fentanyl
- Interventions
- Dexmedetomidine Injection [Precedex], Fentanyl HCl
- First posted
- 2024-04-26
- Last updated
- 2025-02-21
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | intraoperative peritoneal symptoms during appendectomy. | Intraoperative period in minutes | Compare between the efficacy of dexmedetomidine and fentanyl as adjuvants on decreasing the intraoperative peritoneal symptoms such as abdominal discomfort or visceral pain, nausea and vomiting, vagal symptoms like bradycardia and hypotension during appendectomy. |
| Secondary | Assessment of motor block with Modified Bromage scale | 1,6,12,18 and 24 hours | Assessment of motor block with Modified Bromage scale; Bromage Scale: 1. Bromage 0 - patient can move the hip, knee, and ankle. 2. Bromage 1 - patient is unable to move the hip but can move the knee and ankle. 3. Bromage 2 - patient is unable to move the hip and knee but able to move the ankle. * Onset of Bromage 3 (min), Regression to bromage 0 (min). Bromage Scale: 1. Bromage 0 - patient can move the hip, knee, and ankle. 2. Bromage 1 - patient is unable to move the hip but can move the knee and ankle. 3. Bromage 2 - patient is unable to move the hip and knee but able to move the ankle. |
| Secondary | Degree of post-operative analgesia | 1,6,12,18 and 24 hours | VI. The postoperative pain score will be assessed using visual analogue scale (VAS; scored from 0-10, where 0=no pain and 10=the worst pain imaginable) during the recovery room(T0) and at 1,6,12,18 and 24 hours (T1, T6, T12,T18 and T24) in the postoperative period |
| Secondary | Assessment of sensory block by using pin prick method | Time in minutes | Assessment of sensory block by using pin prick method; Time from injection to T10(min) and Time from injection to highest Sensory cephalad spread, Resolution to T10 (min) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06386783
GET https://conductscience.org/api/trials/v1/NCT06386783/registered